Additional file 2: of Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Figure S1. hCD39-specific ASO inhibit degradation of extracellular ATP in a human Burkitt’s lymphoma cell line. (DOCX 662 kb)